Inclusion Criteria:  History of stage I-III breast cancer and free of disease by clinical examination Postmenopausal or premenopausal with ovarian suppression Currently receiving aromatase inhibitors (Anastrozole, Letrozole, or Exemestane) treatment With joint stiffness attributed to the use of aromatase inhibitors Having had joint stiffness for at least 1 months Having had at least 15 days with stiffness in the preceding 30 days  Exclusion Criteria:  Women with recurrent or metastatic breast cancer Women having finished chemotherapy or radiation therapy less than 1 months prior to enrollment Women with history of bleeding disorder Women with joint stiffness attributed to inflammatory arthritis, such as rheumatoid arthritis, spondy loarthritis and osteoarthritis Women having joint stiffness prior to AI treatment Women that have received treatment of any kind for joint stiffness within the last 3 months Women that have previously received the acupuncture treatment before for any reason